Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy.
Authors: Morano A, Iannone L, Palleria C, Fanella M, Giallonardo AT, De Sarro G, Russo E, Di Bonaventura C.
Date: 2018
Scope of interest: Epilepsy
06 99 39
Recup number
You may also be interested in:
Repaglinide administration improves brachial reactivity in type 2 diabetic patients.
Authors: Manzella D, Grella R, Abbatecola AM, Paolisso G.
Date: 2005
Scope of interest: diabetes
Read details
Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.
Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.
Date: 2020
Scope of interest: sars cov 2 therapy
Read details
“Covid Solution”
Authors: Menicagli r
Date: 2020
Scope of interest: infectivology
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
